- Home
- FLG-A vs ZBIO Comparison
FLG-A vs ZBIO Comparison
Compare FLG-A & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLG-A
- ZBIO
- Stock Information
- Founded
- FLG-A N/A
- ZBIO 2019
- Country
- FLG-A
- ZBIO United States
- Employees
- FLG-A N/A
- ZBIO N/A
- Industry
- FLG-A
- ZBIO
- Sector
- FLG-A
- ZBIO
- Exchange
- FLG-A NYSE
- ZBIO NYSE
- Market Cap
- FLG-A N/A
- ZBIO 389.2M
- IPO Year
- FLG-A N/A
- ZBIO 2024
- Fundamental
- Price
- FLG-A N/A
- ZBIO $10.22
- Analyst Decision
- FLG-A
- ZBIO Strong Buy
- Analyst Count
- FLG-A 0
- ZBIO 7
- Target Price
- FLG-A N/A
- ZBIO $32.29
- AVG Volume (30 Days)
- FLG-A N/A
- ZBIO 217.9K
- Earning Date
- FLG-A N/A
- ZBIO 08-16-2025
- Dividend Yield
- FLG-A N/A
- ZBIO N/A
- EPS Growth
- FLG-A N/A
- ZBIO N/A
- EPS
- FLG-A N/A
- ZBIO N/A
- Revenue
- FLG-A N/A
- ZBIO $15,000,000.00
- Revenue This Year
- FLG-A N/A
- ZBIO $206.00
- Revenue Next Year
- FLG-A N/A
- ZBIO $41.92
- P/E Ratio
- FLG-A N/A
- ZBIO N/A
- Revenue Growth
- FLG-A N/A
- ZBIO N/A
- 52 Week Low
- FLG-A N/A
- ZBIO $5.83
- 52 Week High
- FLG-A N/A
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- FLG-A N/A
- ZBIO N/A
- Support Level
- FLG-A N/A
- ZBIO N/A
- Resistance Level
- FLG-A N/A
- ZBIO N/A
- Average True Range (ATR)
- FLG-A 0.00
- ZBIO 0.00
- MACD
- FLG-A 0.00
- ZBIO 0.00
- Stochastic Oscillator
- FLG-A 0.00
- ZBIO 0.00
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.